Follow-The-Filings

BOLT

Bolt Biotherapeutics Inc. COM NEW Equity

No current holdings among tracked managers for this security. See ownership history or the ownership grid or search.

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $7.88M $7.69M $7.7M
Gross profit — — —
Gross margin — — —
Net income -$69.2M -$63.12M -$33.38M
Net margin * -878.6% -820.8% -433.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $105.71M $50.81M $30.26M
Total non-current assets * $54.08M $48.82M $26.49M
Total assets $159.78M $99.63M $56.75M
Total current liabilities $20.46M $15.86M $8.44M
Total non-current liabilities * $26.59M $26.58M $21.81M
Total equity $112.74M $57.2M $26.5M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$69.52M -$61.29M -$39.85M
Cash from investing $71.04M $57.58M $44.3M
Cash from financing $253,000 $108,000 $19,000
Net change in cash $1.77M -$3.6M $4.47M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders